Modulation of cisplatin resistance by 2'-deoxy-5-azacytidine in human ovarian tumor cell lines.
Lenzi R, Frost P, Abbruzzese JL.
Lenzi R, et al. Among authors: frost p.
Anticancer Res. 1994 Jan-Feb;14(1A):247-51.
Anticancer Res. 1994.
PMID: 7513143
The sequential administration of 2'-deoxy-5-azacytidine (DAC) and cisplatin frequently results in synergistic cytotoxicity against human cancer cell lines (Frost P, et al Cancer Res 50:4572-4577, 1990) including the cisplatin resistant HEY ovarian cancer cell line. …
The sequential administration of 2'-deoxy-5-azacytidine (DAC) and cisplatin frequently results in synergistic cytotoxicity against human can …